<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04667208</url>
  </required_header>
  <id_info>
    <org_study_id>Gut barrier study</org_study_id>
    <nct_id>NCT04667208</nct_id>
  </id_info>
  <brief_title>Biomarkers for Intestinal Permeability</brief_title>
  <official_title>Pilot Study: Validation of Easy-to-measure Biomarkers for Intestinal Permeability in Human Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Hohenheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Hohenheim</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to find easy-to-measure biomarkers of intestinal permeability as surrogate&#xD;
      markers for effortful &quot;gold standard&quot; methods.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to find easy-to-measure biomarkers of intestinal permeability as surrogate&#xD;
      markers for effortful &quot;gold standard&quot; methods. In healthy volunteers potential biomarkers for&#xD;
      intestinal permeability as well as an established &quot;gold standard&quot; method for intestinal&#xD;
      permeability (urinary lactulose/mannitol excretion) will be measured at one time point. Using&#xD;
      correlation analyses, potential associations will be assessed and potential biomarkers will&#xD;
      be addressed and discussed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Actual">January 7, 2021</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lactulose / mannitol ratio</measure>
    <time_frame>1 day (Single measurement)</time_frame>
    <description>Urinary excretion of lactulose and mannitol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fecal albumin [ng/mg]</measure>
    <time_frame>1 day (Single measurement)</time_frame>
    <description>Potential easy-to-measure biomarker #1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal calprotectin [ng/mg]</measure>
    <time_frame>1 day (Single measurement)</time_frame>
    <description>Potential easy-to-measure biomarker #2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal zonulin [ng/mg]</measure>
    <time_frame>1 day (Single measurement)</time_frame>
    <description>Potential easy-to-measure biomarker #3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma lipopolysaccharide binding protein [µg/ml]</measure>
    <time_frame>1 day (Single measurement)</time_frame>
    <description>Potential easy-to-measure biomarker #4</description>
  </secondary_outcome>
  <enrollment type="Actual">51</enrollment>
  <condition>Focus: Simplified Method to Assess Intestinal Permeability</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, serum and fecal samples will be stored at -80°C.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteers&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Underweight (BMI &lt;18 kg / m2) and obesity from grade II (BMI ≥ 30 kg / m2)&#xD;
&#xD;
          -  Acute or chronic gastrointestinal diseases&#xD;
&#xD;
          -  Chronically consuming diseases (e.g. chronic tumor disease, florid infections, etc.)&#xD;
&#xD;
          -  Smokers (12 hours before the test and during the test it is not allowed to smoke)&#xD;
&#xD;
          -  Ingestion of intestinal therapeutics, antibiotics, immunosuppressants or similar&#xD;
             within the last 3 months&#xD;
&#xD;
          -  Simultaneous participation in another clinical study&#xD;
&#xD;
          -  Pregnancy / breastfeeding&#xD;
&#xD;
          -  Intolerance to the sugar solution&#xD;
&#xD;
          -  Occurrence of relevant diseases&#xD;
&#xD;
          -  Revocation of consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephan C Bischoff, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Hohenheim, Institute of Nutritional Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Hohenheim</name>
      <address>
        <city>Stuttgart</city>
        <zip>70599</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>December 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 14, 2020</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Hohenheim</investigator_affiliation>
    <investigator_full_name>Stephan C. Bischoff, MD, Professor</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Gastroenterology</keyword>
  <keyword>Gut barrier</keyword>
  <keyword>Intestinal permeability</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

